Pabinafusp alfa Enrolling by Invitation Phase 3 Trials for Mucopolysaccharidosis Type II (MPS II) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05594992An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects